Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|December 17, 2024
Hypoxia-inducible factor-targeting therapy augmented the sensitivity to programmed death ligand-1 blockade by enhancing interferon-γ-induced chemokines in tumor cellsYohei Yabuki, Atsushi Mitsuhashi, Hirokazu Ogino, et al.
Cell Reports|March 4, 2023
Identification of fibrocyte cluster in tumors reveals the role in antitumor immunity by PD-L1 blockadeAtsushi Mitsuhashi, Kazuya Koyama, Hirokazu Ogino, et al.
Cancer Research|November 18, 2008
Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutationsSeiji Yano, Wei Wang, Qi Li, et al.
Cancer Science|December 26, 2023
Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cellsHiroto Yoneda, Atsushi Mitsuhashi, Aito Yoshida, et al.
International Cancer Conference Journal|December 15, 2025
A favorable antitumor efficacy of sotorasib in a patient with KRAS G12C-mutated pulmonary large-cell neuroendocrine carcinomaKeisuke Nakanishi, Hirokazu Ogino, Kojin Murakami, et al.
Respiratory Medicine Case Reports|December 30, 2022
Immune checkpoint inhibitor-related pneumonitis with atypical radiologic features in a patient with anti-aminoacyl-tRNA synthetase antibodySeiya Ichihara, Hirokazu Ogino, Hiroto Yoneda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 2009
E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profilesKenji Ikuta, Seiji Yano, Van The Trung, et al.
Cancer Science|September 21, 2025
Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited-Stage Small-Cell Lung Cancer in the Phase 3 ADRIATIC TrialYoshitaka Zenke, Yoshimasa Shiraishi, Yasushi Goto, et al.
International Cancer Conference Journal|January 27, 2026
A case of thymic carcinoma harboring an FGFR3 S249C mutation with durable disease control on lenvatinibNoriko Bando, Hirokazu Ogino, Kojin Murakami, et al.
Respiratory Medicine Case Reports|July 19, 2024
Transformation of epidermal growth factor receptor mutated lung adenocarcinoma to small-cell carcinoma long after the cessation of tyrosine kinase inhibitor treatment: A case series and literature reviewKenya Miyamoto, Hirokazu Ogino, Takumi Kakimoto, et al.
Pageof 7